Eligibility Requirements
What changed on this page. On 23 August this page replaced a 350% limit with 400% "reduced from 500%" and a Medicare rule about plans that supply Trelegy free. On 4 October we checked GSK's foundation pages: the limit is $47,880 for one person (300% of the poverty guideline), neither 400% nor 500% appears, and the Medicare route requires a Part D plan plus $600 paid for prescriptions this calendar year. Both are corrected above, along with the apply link (which pointed at the co-pay card) and the price (GSK lists $697.73 for 30 days, not about $550).
Confirm before you apply. GSK Patient Access Programs Foundation: gskpaf.org, 1-866-728-4368. Nothing on this page is medical advice or a guarantee of eligibility; GSK decides, not us.
Covered Medications
The following medications are covered by Trelegy Ellipta Savings (via GSK):
How to Apply
- Speak with your healthcare provider about Trelegy Ellipta Savings (via GSK). Your doctor, nurse, or social worker can help determine if you qualify.
- Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
- Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
- Wait for a decision. Approval times and delivery (to your home, your prescriber or a pharmacy) vary by programme, and the programme will tell you how your medicine will arrive.
Check If You Qualify
Use our free Assistance Finder tool to check eligibility for Trelegy Ellipta Savings (via GSK) and other programs that may help reduce your medication costs.
Open Assistance FinderSources and standards behind this page
Drug coverage in the United States is governed by published rules rather than by any one insurer's summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- FDA Orange Book publishes the therapeutic-equivalence ratings that decide whether a generic may be substituted for a brand-name drug.
- FDA generic drug facts sets out what "generic equivalent" means and what a manufacturer must prove.
- CMS prescription drug coverage defines the rules a Medicare drug plan formulary must follow and how it may change mid-year.
- Medicare.gov drug coverage (Part D) states what a Part D plan is required to offer a member.
- CMS prescription drug appeals documents the coverage-determination and exception process when a drug is denied.
- Medicare Plan Compare is the official tool for checking what a specific plan charges for a specific drug at a specific pharmacy.
- Drugs@FDA is the federal database of approved drug products, which establishes whether a covered product exists and in what form.
- DailyMed carries the current FDA labeling for every marketed drug product, including approved strengths and forms.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medication is and how it is used.
- FTC report on pharmacy benefit managers documents how the middlemen between an insurer and a pharmacy shape what a plan actually covers.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how coverage and formularies work. It is not medical advice, and a reader's own plan documents and prescriber decide what applies to them.
Frequently Asked Questions
Yes, if you qualify for the GSK Patient Assistance Program: household income at or below $47,880 for one person (300% of the 2026 poverty guideline; higher in Alaska and Hawaii), and either no prescription drug coverage or a Medicare Part D plan with $600 already paid for prescriptions this calendar year. Call GSK on 1-866-728-4368 or apply at gskpaf.org.
Yes. Commercially insured patients can use the Trelegy savings card to pay as little as $0, subject to a maximum savings limit. It is not available to patients on Medicare, Medicaid or other government coverage.
Trelegy combines three active ingredients (ICS + LAMA + LABA) in one inhaler, replacing the need for two separate inhalers. This simplifies the treatment regimen for COPD and asthma patients.
Related Resources
Get Prescription Savings Alerts
Subscribe to receive updates on patient assistance programs, drug price changes, and new savings opportunities.